Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4; prior tag v3.3.3 is no longer displayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:34:28.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Locations section updated to include Guangdong and Zhejiang as study sites. The HHS Vulnerability Disclosure link in the footer has been removed.
    Difference
    0.3%
    Check dated 2025-12-23T21:16:26.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no study details, eligibility criteria, locations, or contacts were affected.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:04.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding and operating status. The page now displays the study details without that banner.
    Difference
    0.4%
    Check dated 2025-11-18T07:22:01.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the study details, eligibility criteria, and contact information appear unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T20:52:42.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a new government funding operating-status notice for NIH Clinical Center; previous v3.1.0 deletion removed the old version tag.
    Difference
    3%
    Check dated 2025-10-06T07:16:34.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.